← FDA Drug Approvals (Drugs@FDA)

SUMATRIPTAN SUCCINATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PARENTERAL · Approved 2008-07-29

Drug application

FDA Application #

ANDA078318

Application type

Abbreviated New Drug Application (Generic)

Brand name

SUMATRIPTAN SUCCINATE

Generic name

Sumatriptan Succinate

Active ingredients

SUMATRIPTAN SUCCINATE

Dosage form

INJECTABLE

Route

SUBCUTANEOUS

Marketing status

Discontinued

Sponsor

TEVA PARENTERAL

First approval

2008-07-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown